P

Inventor

ZHANG COLIN

US45 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG COLIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INCYTE CORP

32 patents
US7767675B2Aug 3, 2010

Imidazotriazines and imidazopyrimidines as kinase inhibitors

INCYTE CORP85 citations99
US10131667B2Nov 20, 2018

Substituted tricyclic compounds as FGFR inhibitors

INCYTE CORP35 citations98
US9611267B2Apr 4, 2017

Substituted tricyclic compounds as FGFR inhibitors

INCYTE CORP54 citations98
US9533954B2Jan 3, 2017

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

INCYTE CORP42 citations98
US7776874B2Aug 17, 2010

Amido compounds and their use as pharmaceuticals

INCYTE CORP27 citations96
US7304081B2Dec 4, 2007

Amido compounds and their use as pharmaceuticals

INCYTE CORP42 citations96
US11053246B2Jul 6, 2021

Substituted tricyclic compounds as FGFR inhibitors

INCYTE CORP23 citations94
US10813930B2Oct 27, 2020

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

INCYTE CORP27 citations94
US10213427B2Feb 26, 2019

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

INCYTE CORP34 citations94
US9758523B2Sep 12, 2017

Triazolopyridines and triazolopyrazines as LSD1 inhibitors

INCYTE CORP21 citations94
US9695167B2Jul 4, 2017

Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors

INCYTE CORP33 citations94
US9695180B2Jul 4, 2017

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

INCYTE CORP24 citations94
US9695168B2Jul 4, 2017

Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors

INCYTE CORP27 citations94
US7683060B2Mar 23, 2010

Triazolotriazines as kinase inhibitors

INCYTE CORP25 citations92
US7687665B2Mar 30, 2010

2-methylprop anamides and their use as pharmaceuticals

INCYTE CORP24 citations90
US11840534B2Dec 12, 2023

Substituted tricyclic compounds as FGFR inhibitors

INCYTE CORP4 citations86
US10968221B2Apr 6, 2021

Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors

INCYTE CORP6 citations84
US10640503B2May 5, 2020

Imidazopyridines and imidazopyrazines as LSD1 inhibitors

INCYTE CORP7 citations84
US10556908B2Feb 11, 2020

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

INCYTE CORP8 citations84
US10138249B2Nov 27, 2018

Triazolopyridines and triazolopyrazines as LSD1 inhibitors

INCYTE CORP15 citations84
US10125133B2Nov 13, 2018

Substituted [1,2,4]triazolo[1,5-a]pyridines and substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors

INCYTE CORP15 citations84
US10112950B2Oct 30, 2018

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

INCYTE CORP15 citations84
US9957229B2May 1, 2018

Amido compounds and their use as pharmaceuticals

INCYTE CORP4 citations84
US7915408B2Mar 29, 2011

Triazolotriazines as kinase inhibitors

INCYTE CORP6 citations74
US10738052B2Aug 11, 2020

Imidazotriaines and imidazopyrimidines as kinase inhibitors

INCYTE CORP3 citations73
US10047086B2Aug 14, 2018

Imidazopyridines and imidazopyrazines as LSD1 inhibitors

INCYTE CORP2 citations73
US12534463B2Jan 27, 2026

Substituted tricyclic compounds as FGFR inhibitors

INCYTE CORP0 citations63
US12084449B2Sep 10, 2024

Imidazotriazines and imidazopyrimidines as kinase inhibitors

INCYTE CORP0 citations63
US11261191B2Mar 1, 2022

Imidazotriaines and imidazopyrimidines as kinase inhibitors

INCYTE CORP0 citations63
US9873698B2Jan 23, 2018

Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1

INCYTE CORP0 citations52
US9670154B2Jun 6, 2017

Amido compounds and their use as pharmaceuticals

INCYTE CORP0 citations52
US9371323B2Jun 21, 2016

Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1

INCYTE CORP0 citations52

YAO WENQING

9 patents

ZHUO JINCONG

2 patents

INCYTE HOLDINGS CORP

1 patent

ZHANG COLIN

1 patent